Heejong Shin

Mr. Heejong Shin


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HSHeejong Shin
Heejong Shin
HKHwapyung Kim
Hwapyung Kim
GKGwangpyung Kim
Gwangpyung Kim
YKYikyoung Kim
Yikyoung Kim
BKBoyong Kim
Boyong Kim
Excessive glucose absorption is a major contributing factor of metabolic disorders that necessitates effective therapeutic strategies. This study investigates the potential of fermented Aralia cordata extract (FACE) in regulating glucose transport and immune responses under high-glucose stress conditions. Caco-2 intestinal cells and L cells were treated with FACE to determine effects on key glucose-regulating proteins and cytokines. FACE treatment inhibited the expression of glucose transporters SGLT1 and GLUT2 while promoting GLP-1 secretion. This effect was associated with HDAC and somatostatin suppression, along with AMPK-γ upregulation. Notably, FACE inhibited DPP-4 expression, further enhancing GLP-1 stability and function. Immunomodulatory effects also occurred, specifically FACE promotion of T lymphocyte differentiation, with a stronger influence on Th2 cell development. Additionally, FACE increased the secretion of essential molecules for immune balance and inflammation control, including antimicrobial peptides LL-37 and defensin, along with cytokines IL-4 and IL-13. These findings suggest that FACE exerts dual effects of improving glucose regulation and modulating immune responses, highlighting its potential as a novel bioactive material for managing metabolic disorders and enhancing intestinal immunity. Further research is warranted to explore its clinical applicability in therapeutic formulations.

20 April 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
SPSOHYEON PARK
SOHYEON PARK
YPYoonjin Park
Yoonjin Park
HSHeejong Shin
Heejong Shin
BKBoyong Kim
Boyong Kim
SLSeung Gwan Lee
Seung Gwan Lee
Although Allium species are involved in bioactivity, to the best of our knowledge, there is no research on the effects of Allium senescens on drug resistance in hepatocarcinoma. Ultra-high performance liquid chromatography was used to determine the concentration of several bioactive compounds in A. senescens extract; flow cytometry, reverse transcription–quantitative polymerase chain reaction, and siRNA-mediated knockdown to estimate the levels of different markers in HepG2 cells. The quantity of p-coumaric acid in the extract was 4.7291 ± 0.06 μg/mL, and the protein of relevant evolutionary and lymphoid interest (PRELI) in the resistant cells decreased 2.1 times in the presence of p-coumaric acid. The resistant cells strongly downregulated the efflux transporters (ABCB1, ABCC2, and ABCG2) when exposed to the extract or p-coumaric acid and when PRELI was knocked down, in contrast to the influx proteins (OCT-1). Additionally, the extract induced mitochondrial apoptosis and suppressed autophagy. Consequently, the extract and p-coumaric acid attenuated drug resistance of HepG2 cells through the downregulation of PRELI, a key protein associated with the modulation of drug transporter expression, the activation of autophagy, and mitochondrial apoptosis. Our results indicate that A. senescens extract is beneficial in protecting cancer cells against drug resistance and sustaining the efficacy of sorafenib against liver cancer.

30 May 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
HSHeejong Shin
Heejong Shin
EJEunJu Jeong
EunJu Jeong
SLSeung Gwan Lee
Seung Gwan Lee
Exosomes are 30–150 nm extracellular vesicles that play crucial roles in intercellular communication and hold significant potential as biomarkers for non-invasive liquid biopsy. However, the current isolation methods have limitations including being time-consuming, producing low yields, and having high costs. This study presents a novel automated exosome isolation method using EGCG-modified magnetic beads (EGCG@T) optimized for diverse biofluids including plasma, serum, urine, and saliva. We systematically investigated the optimal EGCG:T-Fe3O4 ratio (0.1:1), binding time, elution parameters, and extraction buffer composition for each biofluid type. The developed protocol was successfully integrated into an automated workflow using the Nextractor® NX-Junior platform, combining exosome isolation and protein extraction into a single step. Western blot and ELISA analyses confirmed that the EGCG@T method yielded a significantly higher recovery of exosomal markers (CD9, CD63, CD81, TSG101, and ALIX) compared to conventional PEG precipitation, with the efficiency varying depending on the biofluid. Notably, CD63-positive exosomes were isolated with approximately two-fold higher efficiency from urine and 1.3-fold higher efficiency from saliva using the EGCG@T method. Our findings demonstrated that biofluid-specific optimization is essential for effective exosome isolation, as exosome subpopulations exhibited distinct physicochemical properties across different sample types. This automated, rapid, and efficient exosome isolation method provides a valuable platform for future clinical applications in non-invasive disease diagnosis and monitoring through liquid biopsy.

17 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HSHeejong Shin
Heejong Shin
EJEunJu Jeong
EunJu Jeong
SLSeung Gwan Lee
Seung Gwan Lee
Exosomes are extracellular vesicles of 30-150 nm that play crucial roles in intercellular communication and hold significant potential as biomarkers for non-invasive liquid biopsy. However, current isolation methods face limitations including time-consumption, low yield, and high cost. This study presents a novel automated exosome isolation method using EGCG-modified magnetic beads (EGCG@T) optimized for diverse biofluids including plasma, serum, urine, and saliva. We systematically investigated optimal conditions for EGCG:T-Fe₃O₄ ratio (0.1:1), binding time, elution parameters, and extraction buffer composition for each biofluid type. The developed protocol was successfully integrated into an automated workflow using the Nextractor® NX-Junior platform, combining exosome isolation and protein extraction into a single step. Western blot and ELISA analyses confirmed that the EGCG@T method yielded significantly higher recovery of exosomal markers (CD9, CD63, CD81, TSG101, ALIX) compared to conventional PEG precipitation, with biofluid-dependent efficiency. Notably, CD63-positive exosomes were isolated with approximately two-fold higher efficiency from urine and 1.3-fold higher from saliva using the EGCG@T method. Our findings demonstrate biofluid-specific optimization is essential for effective exosome isolation, as exosome subpopulations exhibit distinct physicochemical properties across different sample types. This automated, rapid, and efficient exosome isolation method provides a valuable platform for future clinical applications in non-invasive disease diagnosis and monitoring through liquid biopsy.